GlucoTrack, Inc. (NASDAQ:GCTK) Short Interest Down 84.6% in March

GlucoTrack, Inc. (NASDAQ:GCTK) was the recipient of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 43,600 shares, a decline of 84.6% from the March 15th total of 283,900 shares. Approximately 0.2% of the shares of the stock are short sold. Based on an average daily trading volume, of 6,280,000 shares, the days-to-cover ratio is presently 0.0 days.

GlucoTrack Stock Performance

Shares of NASDAQ:GCTK traded down $0.01 during mid-day trading on Tuesday, hitting $0.16. The stock had a trading volume of 610,677 shares, compared to its average volume of 1,640,183. The company has a market cap of $4.21 million, a PE ratio of 0.00 and a beta of 0.02. GlucoTrack has a 12-month low of $0.13 and a 12-month high of $99.00. The company’s 50 day moving average is $0.33 and its 200-day moving average is $10.46.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in GlucoTrack stock. Geode Capital Management LLC raised its holdings in GlucoTrack, Inc. (NASDAQ:GCTK) by 315.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 112,787 shares of the company’s stock after acquiring an additional 85,626 shares during the quarter. Geode Capital Management LLC owned about 14.10% of GlucoTrack worth $42,000 at the end of the most recent quarter. Institutional investors own 10.92% of the company’s stock.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.